 Cisplatin has dramatically improved the survival rate of cancer patients but it has also increased the prevalence of hearing and neurological deficits in this population . Cisplatin induces ototoxicity peripheral and central neurotoxicity . This review addresses the ototoxicity and the neurotoxicity associated with cisplatin based chemotherapy providing an integrated view of the potential protective agents that have been evaluated

@highlight It is an overview of the neurotoxicity and ototoxicity induced by cisplatin.
@highlight Contains Tables summarizing studies of oto neuroprotection in different models.
@highlight Clinical trials are discussed comparatively and critically analyzed.
@highlight Mechanisms and strategies of administration of protective agents are discussed.
@highlight Agents tested for the interference in the antitumor activity are indicated.
